CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2017	Jun. 30, 2016
Current Assets:
Cash and cash equivalents	$ 43,393,570	$ 13,203,625
Marketable securities	111,508,225	37,424,221
Accounts receivable, net of allowance for doubtful accounts of $9,371 and $74,546 at June 30, 2017 and 2016, respectively	488,723	513,992
Inventory	580,016	350,524
Other receivables	13,428	236,768
Prepaid expenses	891,284	1,038,155
Other current assets	422,916	183,820
Total current assets	157,298,162	52,951,105
Property and equipment, net	5,245,230	3,969,163
Other long-term assets	30,000	30,000
Total Assets	162,573,392	56,950,268
Current Liabilities:
Accounts payable and accrued expenses	31,366,976	15,188,189
Warrant liabilities	90,706,206
Deferred revenues	170,967	235,372
Total current liabilities	122,244,149	15,423,561
Convertible senior notes - net of unamortized debt issuance costs of $1,915,781 and $2,645,602 at June 30, 2017 and 2016	98,084,219	97,354,398
Other liabilities	1,708,272	1,699,276
Commitments and Contingencies (Note 15)
Stockholders’ Equity (Deficit):
Common stock, $.01 par value; authorized 250,000,000 shares issued 110,344,643 shares and outstanding 110,309,918 shares at June 30, 2017; authorized 155,000,000 shares, issued 95,867,298 shares and outstanding 95,832,573 shares at June 30, 2016	1,103,446	958,672
Capital contributed in excess of par	462,666,366	311,320,651
Treasury stock, at cost: 34,725 shares at June 30, 2017 and 2016	(458,370)	(458,370)
Accumulated deficit	(521,710,899)	(368,504,954)
Accumulated other comprehensive loss	(302,710)	(132,226)
Total Immunomedics, Inc. stockholders' deficit	(58,692,167)	(56,816,227)
Noncontrolling interest in subsidiary	(771,081)	(710,740)
Total stockholders’ deficit	(59,463,248)	(57,526,967)
Total Liabilities and Stockholders' Deficit	162,573,392	56,950,268
Convertible preferred stock
Stockholders’ Equity (Deficit):
Convertible preferred stock, $.01 par value; authorized 10,000,000 shares; 1,000,000 shares issued and outstanding at June 30, 2017: no shares issued and outstanding at June 30, 2016	10,000
Total stockholders’ deficit	$ 10,000

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.